NAUT: nautilus.bio Company Sales Revenue

Nautilus Biotechnology (NAUT) minimizes diagnostic risks by creating a precision protein analysis system to combat cancer. The company's sales volume dynamics demonstrate operational activity, where the 0.00 metric serves as the target level. The business is based on the B2B proteomics segment for pharma behemoths, operating within a stable scientific and technological environment in the US and Europe without geopolitical threats.

NAUT - Nautilus Bio Revenue and Sales Volume over the range 07/04/2022 - 11/14/2026

Analytical breakdowns for Nautilus Biotechnology, Inc. (NAUT)

- market value and analyst target forecast:

Market Chart Nautilus Bio|NAUT - Consensus Target

- market capitalization information:

Market Value Nautilus Biotechnology, Inc.|NAUT - Enterprise Value

- balance sheet net asset value indicators:

Net Assets per Single Share Nautilus Biotechnology|NAUT - Book Capitalization|Market Capitalization to Book Value nautilus.bio|NAUT - Aggregate Company Assets

- debt and solvency information:

Debt to Capital Nautilus Biotechnology|NAUT - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Nautilus Biotechnology|NAUT - Company Aggregate Debts|Debts to Book Value Nautilus Biotechnology, Inc.|NAUT - Company Long-Term Debts|Company Current Liabilities Nautilus Biotechnology|Intermediate Coverage Ratio nautilus.bio

- earnings and market ratios statistics:

NAUT - Company Net Income|Net Profit Forecast Nautilus Biotechnology|NAUT - Price to Earnings Ratio|Projected Price to Earnings Ratio nautilus.bio|NAUT - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nautilus Biotechnology Inc|NAUT - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Nautilus Biotechnology|NAUT - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year nautilus.bio|NAUT - Net earnings per share growth this year|Expected net earnings per share growth next year Nautilus Biotechnology

- company sales and revenue statistics:

NAUT - Company Revenue|Company Revenue Forecast Nautilus Biotechnology|NAUT - P/S Multiple|Forward P/S Multiple NAUT

Summary company analysis:NAUT (Nautilus Bio)

Developing a protein analysis platform within the stable ecosystems of the US and EU ensures predictable demand for Nautilus Biotechnology (NAUT). This indicator consolidates the daily flow of commercial operations, measuring the real balance between shipments and customer purchasing power. By analyzing the company's sales history, an investor can identify dangerous short-term peaks followed by a decline. The stability of this metric confirms the resilience of the business's market valuation.

Key competitors